Award recordCONTRACT

ACTELION PHARMACEUTICALS US, INC.

PIID VA26213F1129· VHA· 262-NETWORK CONTRACT OFFICE 22· 6505 · DRUGS AND BIOLOGICALS· FY2013· $257,518 net obligations· UEI H5BMHLMMNA28· CA

Description

PHARMACEUTICAL DRUGS: TRACLEER BOSENTAN FOR 5 PATIENTS

First action · last action
2012-10-01 · 2013-01-10
Transactions
2
First transaction's obligation
$51,504
Base + all options value (sum of deltas)
$257,518
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA797BP0414
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$257,518$0Base award · 2012-10-01 · this action $51,504 · running total $51,504Modification P00001 · 2013-01-10 · this action $206,015 · running total $257,518
  • Base2012-10-01+$51,504= $51,504
  • Mod P000012013-01-10+$206,015= $257,518
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2012-10-01+$51,504$51,504PHARMACEUTICAL DRUGS: TRACLEER BOSENTAN FOR 5 PATIENTS
Mod P00001· FUNDING ONLY ACTION2013-01-10+$206,015$257,518PHARMACEUTICAL DRUGS: TRACLEER BOSENTAN FOR 5 PATIENTS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI H5BMHLMMNA28)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0477245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$47,052FY2026
36C24526N0181245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$22,235FY2026
36C26026F0024260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$65,500FY2026
36C26026F0017260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$406,538FY2026
36C26025F0209260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$197,168FY2025
36C26025F0107260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$70,630FY2025

Other recipients under 6505 from 262-NETWORK CONTRACT OFFICE 22 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA26216J3405SANOFI VACCINES US INC.262-NETWORK CONTRACT OFFICE 22$209,679FY2016
VA26216P3483JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC.262-NETWORK CONTRACT OFFICE 22$14,960FY2016
VA26216E3967MCKESSON CORPORATION262-NETWORK CONTRACT OFFICE 22$20,913,958FY2016
VA26216P2987PETNET SOLUTIONS, INC.262-NETWORK CONTRACT OFFICE 22$58,136FY2016
VA26216E3446MCKESSON CORPORATION262-NETWORK CONTRACT OFFICE 22$11,612,703FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26213F1129_3600_VA797BP0414_3600 · retrieved 2026-09-26.